Singapore markets open in 2 hours 30 minutes
Straits Times Index
3,212.64 -6.36 (-0.20%) S&P 500
3,970.99 +22.27 (+0.56%) Dow
32,237.53 +132.33 (+0.41%) Nasdaq
11,823.96 +36.56 (+0.31%) Bitcoin USD
28,030.05 +535.52 (+1.95%) CMC Crypto 200
597.33 -21.06 (-3.41%)
Eupraxia Pharmaceuticals Inc. (EPRX.TO)
Toronto - Toronto Real-time price. Currency in CAD
Add to watchlist
At close: 02:41PM EDT
Currency in CAD
Valuation measures4
| Market cap (intra-day) | 85.57M |
| Enterprise value | 65.89M |
| Trailing P/E | N/A |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/sales (ttm) | N/A |
| Price/book (mrq) | 4.21 |
| Enterprise value/revenue | N/A |
| Enterprise value/EBITDA | -3.88 |
Trading information
Stock price history
| Beta (5Y monthly) | N/A |
| 52-week change 3 | 116.75% |
| S&P500 52-week change 3 | -13.21% |
| 52-week high 3 | 5.2300 |
| 52-week low 3 | 0.8000 |
| 50-day moving average 3 | 4.2454 |
| 200-day moving average 3 | 2.8303 |
Share statistics
| Avg vol (3-month) 3 | 28.69k |
| Avg vol (10-day) 3 | 4.28k |
| Shares outstanding 5 | 21.74M |
| Implied shares outstanding 6 | N/A |
| Float 8 | N/A |
| % held by insiders 1 | 12.35% |
| % held by institutions 1 | 20.16% |
| Shares short (14 Mar 2023) 4 | 133.16k |
| Short ratio (14 Mar 2023) 4 | 5.23 |
| Short % of float (14 Mar 2023) 4 | 1.56% |
| Short % of shares outstanding (14 Mar 2023) 4 | 0.62% |
| Shares short (prior month 14 Feb 2023) 4 | 127.16k |
Dividends & splits
| Forward annual dividend rate 4 | N/A |
| Forward annual dividend yield 4 | N/A |
| Trailing annual dividend rate 3 | 0.00 |
| Trailing annual dividend yield 3 | 0.00% |
| 5-year average dividend yield 4 | N/A |
| Payout ratio 4 | 0.00% |
| Dividend date 3 | N/A |
| Ex-dividend date 4 | N/A |
| Last split factor 2 | N/A |
| Last split date 3 | N/A |
Financial highlights
Fiscal year
| Fiscal year ends | 30 Dec 2022 |
| Most-recent quarter (mrq) | 30 Dec 2022 |
Profitability
| Profit margin | 0.00% |
| Operating margin (ttm) | 0.00% |
Management effectiveness
| Return on assets (ttm) | N/A |
| Return on equity (ttm) | N/A |
Income statement
| Revenue (ttm) | N/A |
| Revenue per share (ttm) | N/A |
| Quarterly revenue growth (yoy) | N/A |
| Gross profit (ttm) | N/A |
| EBITDA | N/A |
| Net income avi to common (ttm) | N/A |
| Diluted EPS (ttm) | -1.0700 |
| Quarterly earnings growth (yoy) | N/A |
Balance sheet
| Total cash (mrq) | N/A |
| Total cash per share (mrq) | N/A |
| Total debt (mrq) | N/A |
| Total debt/equity (mrq) | N/A |
| Current ratio (mrq) | N/A |
| Book value per share (mrq) | 0.95 |
Cash flow statement
| Operating cash flow (ttm) | N/A |
| Levered free cash flow (ttm) | N/A |
© 2023 Yahoo. All rights reserved.
